EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study

Shin Nishio iD, Kimio Ushijima iD, Mitsuya Ishikawa iD, Hideki Tokunaga iD, Koji Horie iD, Satoshi Yamaguchi iD, Shiro Suzuki iD, Hideaki Yahata iD, Hitoshi Tsuda iD, Toyomi Satoh iD, Japanese Clinical Oncology Group (JCOG) Gynecologic Cancer Study Group

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e93 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Shin Nishio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan. shinshin@med.kurume-u.ac.jp. Hauptthemen laut MEDLINE: Uterine Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCC, National Cancer Center Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This multi-center retrospective study aimed to clarify the characteristics, diagnostic accuracy, treatment outcomes, and prognostic factors of uterine serous carcinoma (USC) in Japanese women. METHODS: The medical records of 193 patients who were treated between 2006 and 2008 at 24 participating institutions in the Japanese Clinical Oncology Group were examined, and pathological slides of 188 patients were re-checked through central pathology review (CPR), hematoxylin-eosin staining, and immunohistochemistry. RESULTS: USC was confirmed in 144 of the 188 (76.6%) patients using CPR, and only 50% were correctly diagnosed preoperatively. Forty-three patients were diagnosed with non-serous carcinoma, whereas one patient had metastasis from another organ. The average age was 65.7 years, and 19% of patients had a history of other cancers. The incidence of stage III-IV disease was 52.8%, and lymph node metastasis was found in 28.5% of patients. Extrauterine spread and distant metastasis occurred in 39% and 14% of patients, respectively. The 2-year overall survival and progression-free survival (PFS) rates were 56% and 42%, respectively. The PFS of patients with stage I and II who underwent complete staging surgery was 92.3%, and that of those without lymph node dissection or omentectomy was 33.3%. Patients with USC had a significantly worse prognosis than 43 patients with non-serous carcinoma. CONCLUSION: USC in Japanese women has characteristics different from those of endometrioid carcinoma, worse prognosis, and is difficult to diagnose preoperatively. Complete surgical staging is necessary even for early-stage disease. Additionally, new adjuvant treatment strategies, including molecular targeted therapy, should be explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsCystadenocarcinoma, SerousHumansFemaleAgedRetrospective StudiesMiddle AgedPrognosisJapanAged, 80 and overNeoplasm StagingAdultLymphatic MetastasisProgression-Free SurvivalEast Asian People

Stichwörter der Autor:innen

Diagnostic AccuracyEndometrial CancerJapanese WomenPrognostic FactorsUterine Serous Carcinoma

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan. shinshin@med.kurume-u.ac.jp.
  • Department of Obstetrics and Gynecology, JCHO Kurume General Hospital, Kurume, Japan.
  • Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.
  • Department of Gynecology, Saitama Cancer Center, Ina, Japan.
  • Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Japan.

ORCID-Profile: Shin Nishio, Kimio Ushijima, Mitsuya Ishikawa, Hideki Tokunaga, Koji Horie, Satoshi Yamaguchi, Shiro Suzuki, Hideaki Yahata, Hitoshi Tsuda, Toyomi Satoh

Förderung

  • NCC
  • National Cancer Center Japan

Zitieren

APA

Nishio, S., Ushijima, K., Ishikawa, M., Tokunaga, H., Horie, K., Yamaguchi, S., Suzuki, S., Yahata, H., Tsuda, H., Satoh, T., & Japanese Clinical Oncology Group (JCOG) Gynecologic Cancer Study Group (2025). Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e93

Vancouver

Nishio S, Ushijima K, Ishikawa M, Tokunaga H, Horie K, Yamaguchi S, et al. Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e93

BibTeX
@article{Nishio2025,
  author = {Nishio, Shin and Ushijima, Kimio and Ishikawa, Mitsuya and Tokunaga, Hideki and Horie, Koji and Yamaguchi, Satoshi and Suzuki, Shiro and Yahata, Hideaki and Tsuda, Hitoshi and Satoh, Toyomi and Japanese Clinical Oncology Group (JCOG) Gynecologic Cancer Study Group, Japanese Clinical Oncology Group (JCOG) Gynecologic Cancer Study Group},
  title = {Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e93}
}
Kostenlos starten →